Evolva Stock

Detail Data
Volume (24h): 1,502 shares
P/E Ratio: 8.25
Forward P/E: -0.46
EPS: 0.14 CHF
Forward EPS: -2.5 CHF
Number of Shares: 7,211,550 shares
Market Capitalization: 8,329,340.00 CHF

Dividend

Dividend Value
Dividend Amount According to our data, the company Evolva does not currently pay dividends.
Annual Yield %: -
Ex-dividend Date: -
5-Year Avg Yield %: -
Payout Ratio: -
Last Dividend Value: -
Last Dividend Date: -

Analyst Forecast

Most analysts have issued a none recommendation for Evolva stock. The current number of analysts covering this company is No analyst coverage. The highest target price is / while the lowest target price is / The median target valuation set by analysts is / These forecasts and recommendations provide insight into how analysts view the future stock performance of Evolva.
Analysts Recommendation
Issued Recommendation: According to our data, the recommendation for Evolva stock is: none
Number of Analysts: Evolva is not covered by analysts.
Highest Target Price: /
Lowest Target Price: /
Median Target Price: /

Fundamental Indicators

Indicator Data
Total Revenue: /
Net Income: 1,043,800.00 CHF
Price-to-Book (P/B): 1.26
PEG Ratio: /
Exchange: Swiss
Industry: Biotechnology
Sector: Healthcare
Number of Employees:
Country: Switzerland

Where to Buy Evolva Stock?

You can purchase Evolva stock on the Swiss under the ticker symbol: EVE.SW. Several stock brokers or banks offer trading services for these stocks. Popular stock brokers like XTB and eToro allow you to buy real stocks and ETFs with zero or minimal commissions. Banks usually charge higher fees. Remember, investing in stocks involves risks, so it's important to carefully consider your financial situation and investment goals.

1

Real stocks and ETFs. Low minimum deposit, only 50 EUR. Option to copy trades. Advanced stock analysis and free education.

Trustpilot rating 4.4/5 Google play rating 4.2/5
Invest in Stocks with eToro
★★★★★ 5.0
2

Real stocks and ETFs + free demo account. Low fees + fast customer support. More than 5,200 instruments available for trading. Free training and education. Regular live streams on YouTube.

Trustpilot rating 3.6/5 Google play rating 4.5/5
Try Free Demo Account
★★★★☆ 4.8
Risk warning: Trading CFDs involves a high risk of financial loss. Between 51%-eToro -89% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

More Information on Evolva Stock

Indicator Value
Company Revenue: -
EBITDA: 3,699,900.00 CHF - Positive EBITDA indicates profitable operations before interest, taxes, depreciation, and amortization.
Earnings Per Share: 0.14 CHF
Book Value Per Share: 0.92 CHF
Total Cash: 6,753,300.00 CHF
Total Cash per Share: 0.94 CHF
Total Debt: -
Debt to Equity Ratio: -
Quick Ratio 7.86
Current Ratio 7.98
Free Cash Flow 1,940,413.00 CHF
Operating Cash Flow -2,439,300.00 CHF
Gross Margins -
EBITDA Margins -
Operating Margins -
Profit Margins -
Return on Assets 5.7 %
Return on Equity 17.2 %
Earnings Growth (1 year) -
Revenue Growth (1 year) -
Quarterly Earnings Year-over-Year Growth -
Market Capitalization 8,329,340.00 CHF
Enterprise Value 1,720,273.00 CHF
EV/Revenue -
EV/EBITDA 0.465
Float Shares 5,353,063 shares
Shares Outstanding 7,211,550 shares
Held Percent Insiders 0.42 %
Held Percent Institutions 3.36 %
Shares Short -
Shares Short Prior Month -
Date Short Interest -
Short Percentage of Total Shares -
Short Ratio -
Beta -0.08
Short Percentage of Float -
Implied Shares Outstanding 7,211,550

Frequently Asked Questions (FAQ)

According to our data, the company Evolva does not pay dividends yet, even in 2025.

Evolva shares are traded on the Swiss stock exchange under the ticker: EVE.SW. You can buy or trade them through a variety of stock brokers who provide real stock trading services.

No prediction or recommendation from analysts has been issued for Evolva shares yet.

The total number of Evolva shares on the exchange is 7,211,550.00 shares, which at the current market capitalization gives the company a total valuation of 8,329,340.00 CHF.